SLC2A3 and cancer: Key glycolytic enzymes that could be novel targets for cancer therapy must be identified.[16] In this study, PDK1 knockdown significantly downregulated glycolytic enzymes, including HK2, LDHA, and MCT4, but not GLUT3, in both HeLa and SiHa cells.